These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22009747)

  • 1. Regulation of breast cancer-induced bone lesions by β-catenin protein signaling.
    Chen Y; Shi HY; Stock SR; Stern PH; Zhang M
    J Biol Chem; 2011 Dec; 286(49):42575-42584. PubMed ID: 22009747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
    Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
    J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
    Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
    J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis.
    Li Z; Schem C; Shi YH; Medina D; Zhang M
    Clin Exp Metastasis; 2008; 25(4):389-400. PubMed ID: 17965942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/β-catenin signaling and colon cancer cell tumorigenesis.
    Wang W; Liu H; Wang S; Hao X; Li L
    Cell Res; 2011 May; 21(5):730-40. PubMed ID: 21321609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
    Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
    Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.
    Saegusa M; Hashimura M; Kuwata T
    Lab Invest; 2012 Apr; 92(4):511-21. PubMed ID: 22231735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting beta-catenin signaling to induce apoptosis in human breast cancer cells by z-guggulsterone and Gugulipid extract of Ayurvedic medicine plant Commiphora mukul.
    Jiang G; Xiao X; Zeng Y; Nagabhushanam K; Majeed M; Xiao D
    BMC Complement Altern Med; 2013 Aug; 13():203. PubMed ID: 23914993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25(OH)
    Lu G; Li J; Chu J; Jin S; Fu Z; Miao D; Yin Y
    Biomed Pharmacother; 2017 Nov; 95():1033-1039. PubMed ID: 28922720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.
    Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A
    Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
    Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
    Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion.
    Shin CS; Her SJ; Kim JA; Kim DH; Kim SW; Kim SY; Kim HS; Park KH; Kim JG; Kitazawa R; Cheng SL; Civitelli R
    J Bone Miner Res; 2005 Dec; 20(12):2200-12. PubMed ID: 16294273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.